Significant Ownership of M.D. Arie Belldegrun

Location
Los Angeles, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by M.D. Arie Belldegrun.

Notify me when M.D. Arie Belldegrun files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of M.D. Arie Belldegrun

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ALLO Allogene Therapeutics, Inc. Common Stock 5.8% $18,149,993 +$794,362 13,248,170 +4.6% Arie Belldegrun, M.D. 31 Dec 2025

Schedules 13D/G Reported by M.D. Arie Belldegrun:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.